Generated by AI
Aquestive Therapeutics Inc. is a specialty pharmaceutical company focused on developing and commercializing oral and non-invasive drug-delivery therapies. The company’s portfolio includes approved products such as Libervant for seizure clusters, along with licensed medicines delivered through its proprietary PharmFilm technology. This platform is designed to simplify administration of complex treatments using thin-film formulations that dissolve in the mouth, supporting use cases where traditional pills, injections, or infusions may be less practical. Aquestive Therapeutics also operates as a contract development and manufacturing partner, producing and packaging pharmaceutical products for licensees and customers. Its business is centered on central nervous system therapies, emergency allergy treatments, and other conditions where alternative delivery methods can improve usability and access to care. Headquartered in Warren, New Jersey, Aquestive Therapeutics plays a niche role in the broader pharmaceutical market through differentiated formulation science and specialized manufacturing capabilities.
Website184 Liberty Corner Road
Warren, NJ, 07059
United States
The latest articles about AQST.
Aquestive Therapeutics Inc (AQST) navigates quarterly revenue fluctuations while advancing Anifilm toward a March 2027 FDA decision and securing a $10 million upfront licensing deal for Libervant.
Summary of Nov 18's posts. Generated by AI.
Summary of Nov 18's posts. Generated by AI.
Summary of Feb 2's posts. Generated by AI.
Summary of Oct 15's posts. Generated by AI.
Investors talking about AQST also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.